Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Amanda Vansant

Physician Assistant Eugene, OR Physician Assistant

NPI 1295071496 CMS profile 58115

74B Centennial Loop, Suite 100, Eugene, OR 97401

Open in the dashboard

General payments

$11,778

329 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Amanda Vansant of Eugene, OR is reported in the CMS Open Payments database as having received $11,778 across 329 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,566 107
2024 General $1,829 91
2023 General $1,283 69
2022 General $3,188 44
2021 General $3,912 18

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Amanda Vansant
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Amanda Vansant were reported at $1,566. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Amanda Vansant Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $3,912 $132 $37–$438 $132
2022 $3,188 $155 $48–$522 $149
2023 $1,283 $167 $52–$557 $160
2024 $1,829 $178 $55–$600 $164
2025 $1,566 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $7,191 121 payments
  2. Alkermes, Inc. $1,210 39 payments
  3. Otsuka America Pharmaceutical, Inc. $419 20 payments
  4. ITI, Inc. $405 21 payments
  5. Ironshore Pharmaceuticals Inc. $395 23 payments
  6. Corium, Inc. $343 27 payments
  7. Vanda Pharmaceuticals Inc. $300 17 payments
  8. Axsome Therapeutics, Inc. $207 7 payments
  9. Supernus Pharmaceuticals, Inc. $181 6 payments
  10. Tris Pharma Inc $180 9 payments
  11. Other $945 39 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $5,989 322 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $5,500 5 payments
  3. Travel and Lodging $289 2 payments
Products named General payments · program years 2021–2025
  1. VRAYLAR $6,699 74 payments
  2. LYBALVI Cns $724 27 payments
  3. LYBALVI Cns $440 11 payments
  4. ARISTADA Cns $437 22 payments
  5. ARISTADA Cns $437 22 payments
  6. REXULTI $395 19 payments
  7. LYBALVI Cns $389 7 payments
  8. LYBALVI Cns $389 7 payments
  9. VIVITROL $385 10 payments
  10. ARISTADA Cns $385 18 payments
  11. Other $4,212 231 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

329 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Oregon

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record